Molecular descriptors influencing melting point and their role in classification of solid drugs

Journal of Chemical Information and Computer Sciences

Volumn 43, Issue 4, 2003, Pages 1177-1185

  Bergström, Christel A S ^a   Norinder, Ulf ^a,c   Luthman, Kristina ^b   Artursson, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMS; COMPUTER PROGRAMMING; ELECTRONS; HYDROPHILICITY; MELTING; MOLECULAR DYNAMICS; SOLUBILITY;

MOLECULAR DESCRIPTORS;

DRUG PRODUCTS;

DRUG;

ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; METHODOLOGY; PHYSICAL CHEMISTRY; STRUCTURE ACTIVITY RELATION;

CHEMISTRY, PHYSICAL; MODELS, CHEMICAL; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0041698448     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci020280x     Document Type: Article

References (29)

1. Yalkowsky, S. H.; Valvani, S. C. Solubility and partitioning I: Solubility of nonelectrolytes in water. J. Pharm. Sci. 1980, 69, 912-922.
2. Yalkowsky, S. H. Solubility and partitioning V: Dependence of solubility on melting point. J. Pharm. Sci. 1981, 70, 971-973.
3. Yalkowsky, S. H.; Pinal, R. Estimation of the aqueous solubility of complex organic compounds. Chemosphere 1993, 26, 1239-1261.
4. Jain, N.; Yalkowsky, S. H. Estimation of the aqueous solubility I: application to organic nonelectrolytes. J. Pharm. Sci. 2001, 90, 234-252.
5. Ran, Y.; Yalkowsky, S. H. Prediction of drug solubility by the general solubility equation (GSE). J. Chem. Inf. Comput. Sci. 2001, 41, 354-357.
6. Law, D.; Wang, W.; Schmitt, E. A.; Long, M. A. Prediction of poly(ethylene) glycol-drug eutectic compositions using an index based on the van't Hoff equation. Pharm. Res. 2002, 19, 315-321.
7. Nikmo, J.; Kukkonen, J.; Riikonen, K. A model for evaluating physicochemical substance properties required by consequence analysis models. J. Hazard. Mater. 2002, 91, 43-61.
8. Mitchell, B. E.; Jurs, P. C. Prediction of aqueous solubility of organic compounds from molecular structure. J. Chem. Inf. Comput. Sci. 1998, 38, 489-496.
9. Abraham, M. H.; Le, J. The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. J. Pharm. Sci. 1999, 88, 868-880.
10. Jorgensen, W. L.; Duffy, E. M. Prediction of drug solubility from Monte Carlo simulations. Bioorg. Med. Chem. Lett. 2000, 10, 1155-1158.
11. Huuskonen, J. Estimation of aqueous solubility in drug design. Comb. Chem. High Throughput Screening 2001, 4, 311-316.
12. Gao, H.; Shanmugasundaram, V.; Lee, P. Estimation of aqueous solubility of organic compounds with QSPR approach. Pharm. Res. 2002, 19, 497-503.
13. Bergström, C. A. S.; Norinder, U.; Luthman, K.; Artursson, P. Experimental and computational screening models for the prediction of aqueous drug solubility. Pharm. Res. 2002, 182-188.
14. Bergström, C. A. S.; Strafford, M.; Lazorova, L.; Avdeef, A.; Luthman, K.; Artursson, P. Absorption classification of oral drugs from molecular surface properties. J. Med. Chem. 2003, 46, 558-570.
15. Stenberg, P.; Norinder, U.; Luthman, K.; Artursson, P. Experimental and computational screening models for the prediction of intestinal drug absorption. J. Med. Chem. 2001, 44, 1927-1937.
16. The Merck Index, 12th ed.; Budavari, S., Ed.; Merck & Co, Inc: Whitehouse Station, 1996.
17. Molconn-Z v.3 15S, Hall Associates Consulting, Quincy, MA.
18. Olsson, T.; Sherbukhin, V. Synthesis and Structure Administration (SaSA), AstraZeneca R & D Mölndal.
19. Pearlman, R. S.; Smith, K. M. New software tools for chemical diversity, in 3D-QSAR and drug design; Kubinyi, H., Martin, Y., Folkers, G., Eds.; Kluwer Academic: Dordrecht, 1997.
20. Connectivity in structure-activity analysis; Kier, L. B., Hall, L. H., Eds.; Research Studies Press: John Wiley and Sons: Letchwort, 1986.
21. The program MAREA is available upon request from the authors. The program is provided free of charge for academic users. Contact Johan Grasjö (e-mail johan.grasjo@farmaci.uu.se).
22. Gajewski, J. J.; Gilbert, K. E.; McKelvey, J. MMX an enhanced version of MM2. Adv. Mol. Model. 1990, 2, 65-92.
23. Jackson, E. J. A users guide to principal components; Wiley: New York, 1991.
24. Höskuldsson, A. PLS regression methods. J. Chemometrics 1988, 2, 211-228.
25. Simca-P v. 8.0; Umetrics AB, Box 7960, SE-907 19 Urneå, Sweden.
26. Li, Z. J.; Ojala, W. H.; Grant, D. J. Molecular modeling study of chiral drug crystals: lattice energy calculations. J. Pharm. Sci. 2001, 90, 1523-1539.
27. Adsmond, D. A.; Grant, D. J. Hydrogen bonding in sulfonamides. J. Pharm. Sci. 2001, 90, 2058-2077.
28. Yamaoka, Y.; Roberts, R. D.; Stella, V. J. Low-melting phenytoin prodrugs as alternative oral delivery modes for phenytoin: a model for other high-melting sparingly water-soluble drugs. J. Pharm. Sci. 1983, 72, 400-405.
29. Rollinger, J. M.; Gstrein, E. M.; Burger, A. Crystal forms of torasemide: new insights. Eur. J. Pharm. Biopharm. 2002, 53, 75-86.